RxDoctor Payments DataLook up a doctor →

Joseph Goldberg

Psychiatry · New Canaan, CTNPI 1194948323

Payments from drug & device makers

$914,439in general payments, 2019–2025

Across 904 payments — averaging $1011.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$308K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$145K
  • Alkermes, Inc.$118K
  • E.r. Squibb & Sons, L.L.C.$104K
  • Axsome Therapeutics, Inc.$82K
  • AbbVie$79K
  • plus $80K from 10 others
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$900

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$914,439 in reported general payments places this provider in the 95th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Other psychiatry in New Canaan

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →